Skip to main content
$55.18 -$0.22 (-0.4%)

04:00 PM EDT on 09/26/23

Axonics Modulation (NASDAQ:AXNX)

CAPS Rating: No stars

Current Price $55.18 Mkt Cap $2.8B
Open $55.02 P/E Ratio -82.56
Prev. Close $55.40 Div. (Yield) $0.00 (0.0%)
Daily Range $54.76 - $59.95 Volume 463,404
52-Wk Range $47.59 - $77.20 Avg. Daily Vol. 701,712

Caps

How do you think NASDAQ:AXNX will perform against the market?

Add Stock to CAPS Watchlist

All Players

7 Outperform
0 Underperform
 

All-Star Players

2 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AXNX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:AXNX Summary

Fools bullish on NASDAQ:AXNX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about AXNX.

Recs

0
Member Avatar pregu (86.19) Submitted: 12/4/2018 8:20:33 AM : Outperform Start Price: $15.00 NASDAQ:AXNX Score: +215.72

I almost peed myself when I learned Axonics was going public and felt a tingle in my S-2 foramen.

Sacral nerve stimulation is a fast growing industry with currently only one other player (MDT's Interstim). The Interstim product has been neglected due to lack of competition and current clinical data and product assessment shows that Axonics has a better product and will take significant share. Nuvectra (NVTR) has another competitive product that may also enter market soon but Axonics looks poised to take the lead based on their clinical-data based PMA as opposed to NVTR's paper-based PMA. NVTR also has a spinal cord stimulation product (SCS) and their hand in deep brain stimulation so they may be distracted in terms of the sacral nerve stimulation..

Regardless of what happens with AXNX's stock, the real winner here is patients.

Recs

0
Member Avatar Bigsef77 (48.40) Submitted: 11/12/2018 2:21:11 PM : Outperform Start Price: $15.07 NASDAQ:AXNX Score: +212.47

Insiders

Leaderboard

Find the members with the highest scoring picks in AXNX.

Score Leader

pregu

pregu (86.19) Score: +215.72

The Score Leader is the player with the highest score across all their picks in AXNX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
pregu 86.19 11/7/2018 Outperform 5Y $15.00 +268.97% +53.24% +215.72 1 Comment
Bigsef77 48.40 11/12/2018 12/17/2019 Outperform 3Y $15.07 +267.37% +54.91% +212.47 1 Comment
foolishfun4me 82.26 2/28/2019 Outperform 5Y $21.24 +160.57% +52.38% +108.19 0 Comment
TMFSarahGen 95.25 5/29/2019 Outperform 5Y $32.88 +68.32% +53.63% +14.69 0 Comment
Lademann < 20 5/12/2021 Outperform 5Y $51.78 +6.90% +3.22% +3.67 0 Comment
gunterle 69.95 5/27/2020 Outperform 5Y $39.34 +40.68% +40.79% -0.10 0 Comment
NXPR < 20 3/29/2023 Outperform 5Y $55.39 -0.08% +6.35% -6.44 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AXNX.